HIGH QUALITY
PRODUCTS,
DRIVEN BY
GERMAN TECHNOLOGY
COMPANY OVERVIEW
With manufacturing based in Germany, Optimed ensures consistent quality and compliance with national, European (CE certification), and international standards. Its products are available in more than 40 countries worldwide, backed by extensive experience in medical device approval and regulation.
PRODUCT OVERVIEW
FOR THE TREATMENT OF DEEP VEIN THROMBOSIS (DVT) AND POST-THROMBOTIC SYMDROME (PTS)
The Sinus-Venous Stent is Optimed’s most advanced stent, specifically developed for venous indications. Its unique hybrid design combines strong radial force with high flexibility, enabling effective treatment of even severe venous obstructions.
Key Features:
- Seamless one-piece nitinol construction
- High-grade electro-polishing for smooth surfaces
- Minimal stent shortening
- Precise delivery with radiopaque markers
- Smooth pull-back technique with anti-jump control
- Braided sheath with flexible tip for easier navigation
Indications:
-
- Recurrent iliofemoral vein thrombosis
- Post-thrombotic syndrome (PTS)
- May-Thurner Syndrome
- Deep Vein Thrombosis (DVT)
- Tumor-related stenosis
The Sinus-XL Stent is engineered for challenging straight vessel anatomies, providing exceptional stability and visibility. Its closed-cell design delivers outstanding radial force, while specialized deployment technology ensures precise placement without migration.
Key Features:
-
Closed-cell design for maximum radial force in straight vessel segments
-
Tantalum markers at both ends for excellent radiographic visibility
-
Anti-Jump Technique™ to prevent migration during deployment
Indications:
-
Aortic stenosis and dissections
-
Vena cava compression syndrome
-
Obstructions of the vena cava
-
Endoleak type Ia and Ib
-
Oblique hybrid design tailored for iliac vein compression
-
Closed-cell sections for radial strength, open-cell areas for flexibility
-
Precise repositionability for accurate stent deployment
-
Oblique Power Crown design to reduce risk of thrombosis or re-occlusion
Indication:
-
May-Thurner Syndrome (PTS)
The CO₂-Angioset is a sterile, single-use system designed for vascular imaging using medical-grade carbon dioxide (purity ≥ 99.55%). It provides a safe and effective alternative to iodine-based contrast agents, particularly for patients with renal insufficiency, iodine intolerance, or hyperthyroidism. With excellent imaging quality—even in small vessels such as the infrapopliteal segment—it supports reliable diagnosis while reducing contrast-related risks.
-
Sterile disposable system using medical-grade CO₂
-
Recommended for patients with renal insufficiency or iodine intolerance
-
Provides high-quality imaging, especially in smaller vessels
-
Reduces side effects compared to iodinated contrast media
-
CO₂ eliminated naturally via the lungs (no renal clearance required)
Indications:
-
Renal insufficiency
-
Intolerance to iodine-based contrast media
-
Hyperthyroidism
-
Pathological shunts
-
Detection of bleeding sources
-
Abdominal aortic aneurysm
-
Reduction of iodine-related side effects
Range of Applications:
-
Pelvic arteries
-
Leg arteries
-
Renal arteries
-
Visceral arteries
-
Hemodialysis shunts
-
Venous imaging (≤ 40 ml per injection)
-
Retrograde portal artery imaging with TIPS
| PHYSICS | CONTRAST AGENTS | CO2 |
|---|---|---|
| Viscosity | + | – |
| Flow Rate | – | + |
| Radiopacity | Positive Contrast Agent | Negative Contrast Agent |
| Molecular structure (Complexity) | High | Low |
| Degradation / Excretion | Kidney | Lungs (primary) |
| Contraindication | – Allergic reaction – Renal failure – Hyper/hypothyroidism | – Arterial septal defect – Ventricular septal defect – Open foramen ovale – Poor lung function |
| Binding capacity to erythrocyte | CO2 (high) vs O2 (low) | |
| Henderson / Hasselbalch equation | PH-deviation with possible changes in acid-base balance |
